Literature DB >> 35464288

Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?

Eda Kaya1,2, Aleko Zedginidze1,2, Lars Bechmann1,2, Ali Canbay1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35464288      PMCID： PMC9023843          DOI： 10.21037/hbsn-21-548

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  MAFLD identifies patients with significant hepatic fibrosis better than NAFLD.

Authors:  Sakura Yamamura; Mohammed Eslam; Takumi Kawaguchi; Tsubasa Tsutsumi; Dan Nakano; Shinobu Yoshinaga; Hirokazu Takahashi; Keizo Anzai; Jacob George; Takuji Torimura
Journal:  Liver Int       Date:  2020-12       Impact factor: 5.828

Review 2.  A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Authors:  Mohammed Eslam; Philip N Newsome; Shiv K Sarin; Quentin M Anstee; Giovanni Targher; Manuel Romero-Gomez; Shira Zelber-Sagi; Vincent Wai-Sun Wong; Jean-François Dufour; Jörn M Schattenberg; Takumi Kawaguchi; Marco Arrese; Luca Valenti; Gamal Shiha; Claudio Tiribelli; Hannele Yki-Järvinen; Jian-Gao Fan; Henning Grønbæk; Yusuf Yilmaz; Helena Cortez-Pinto; Claudia P Oliveira; Pierre Bedossa; Leon A Adams; Ming-Hua Zheng; Yasser Fouad; Wah-Kheong Chan; Nahum Mendez-Sanchez; Sang Hoon Ahn; Laurent Castera; Elisabetta Bugianesi; Vlad Ratziu; Jacob George
Journal:  J Hepatol       Date:  2020-04-08       Impact factor: 25.083

3.  Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

Authors:  David van der Poorten; Caroline F Samer; Mehdi Ramezani-Moghadam; Sally Coulter; Marina Kacevska; Dennis Schrijnders; Lindsay E Wu; Duncan McLeod; Elisabetta Bugianesi; Mina Komuta; Tania Roskams; Christopher Liddle; Lionel Hebbard; Jacob George
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

4.  A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD.

Authors:  Yusuf Yilmaz; Christopher D Byrne; Giovanni Musso
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-12-09       Impact factor: 3.869

5.  Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Authors:  Ramy Younes; Olivier Govaere; Salvatore Petta; Luca Miele; Dina Tiniakos; Alastair Burt; Ezio David; Fabio Maria Vecchio; Marco Maggioni; Daniela Cabibi; Duncan McLeod; Maria Jesus Pareja; Anna Ludovica Fracanzani; Rocio Aller; Chiara Rosso; Javier Ampuero; Rocío Gallego-Durán; Angelo Armandi; Gian Paolo Caviglia; Marco Y W Zaki; Antonio Liguori; Paolo Francione; Grazia Pennisi; Antonio Grieco; Giovanni Birolo; Piero Fariselli; Mohammed Eslam; Luca Valenti; Jacob George; Manuel Romero-Gómez; Quentin Mark Anstee; Elisabetta Bugianesi
Journal:  Gut       Date:  2021-02-04       Impact factor: 23.059

Review 6.  An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD.

Authors:  Grace En Hui Lim; Ansel Tang; Cheng Han Ng; Yip Han Chin; Wen Hui Lim; Darren Jun Hao Tan; Jie Ning Yong; Jieling Xiao; Chloe Wen-Min Lee; Mark Chan; Nicholas Ws Chew; Eunice Xiang Xuan Tan; Mohammad Shadab Siddiqui; Daniel Huang; Mazen Noureddin; Arun J Sanyal; Mark D Muthiah
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-04       Impact factor: 11.382

7.  Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.

Authors:  Donghee Kim; Peter Konyn; Keeryth K Sandhu; Brittany B Dennis; Amanda C Cheung; Aijaz Ahmed
Journal:  J Hepatol       Date:  2021-08-08       Impact factor: 30.083

8.  NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.

Authors:  Qi Huang; Xiantong Zou; Xin Wen; Xianghai Zhou; Linong Ji
Journal:  Front Med (Lausanne)       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.